REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 600 participants.

Also called NCT06399692

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 600 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06399692
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06399692. Randomized; single masking; primary purpose prevention. Start 2024-09-16 (actual); primary completion 2033-03-15 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women
Acronym
RECHARGE:W
Lead sponsor
Weill Medical College of Cornell University (class: other)
Collaborator
Patient-Centered Outcomes Research Institute (class: other)
Collaborator
Icahn School of Medicine at Mount Sinai (class: other)

Record details

Record id
cardio:ct-nct06399692
Content hash
3fa42d7122a346bf6ae6704c4c4bb7a59c22ac23f5852ccf92c34be1f19f2428